Healthcare

  • ROBOTICS AND HEALTHCARE: Is the EU rising to the Opportunities and Threats?

    Technology is rapidly transforming the healthcare sector as we know it. While it is generally accepted that eHealth and mHealth can improve citizens’ possibility to monitor and evaluate their health, there is less knowledge about the wide range of uses of robotics in healthcare  – from  service robots in hospitals who deliver bed-linen and retrieve…

  • Brexit’s Impact on Healthcare and Life Sciences

    Health and life sciences are heavily regulated sectors, which directly employ a significant proportion of the workforce across health and care delivery, pharmaceuticals, research and development, education, animal health and the many other issues covered by the sector. The sector drives a significant percentage of trade inside and outside the EU market and healthcare consumes,…

  • Another call for action on the fight against AMR

    Last week, the Review on Antimicrobial Resistance, published its final report on Tackling Drug-Resistant Infections Globally. The document represents an important call for action in the global fight against AMR and is expected to have a huge impact on the current debate. Setting the scene, the report states that 700,000 people die of drug-resistant infections…

  • First steps taken but still a long way to go to tackle antimicrobial resistance

    Last week, the European Parliament adopted its report on veterinary medicinal products advocating for the banning of collective and preventive antibiotic treatment of animals. The vote represents an important step in the fight against antimicrobial resistance (AMR) in Europe and Commissioner Andriukaitis strongly welcomed the EP report and the good work of Rapporteur, Mrs Grossetête.…

  • Meeting the challenges of patents, innovation and access to global health

    Over the past years, and as a response to the financial crisis in Europe, the pharmaceutical sector has felt the squeeze of cuts in healthcare spending. Not only have pharmaceutical companies had to re-adjust to the new market conditions, they have also been under the close scrutiny of the European Commission amidst claims of excessive…

Back to top